AplusB: A Web Application for Investigating A + B Designs for Phase I Cancer Clinical Trials.pdf (1.76 MB)
AplusB: A Web Application for Investigating A + B Designs for Phase I Cancer Clinical Trials
journal contributionposted on 2018-04-27, 10:49 authored by Graham M. Wheeler, Michael J. Sweeting, Adrian P. Mander
In phase I cancer clinical trials, the maximum tolerated dose of a new drug is often found by a dose-escalation method known as the A + B design. We have developed an interactive web application, AplusB, which computes and returns exact operating characteristics of A + B trial designs. The application has a graphical user interface (GUI), requires no programming knowledge and is free to access and use on any device that can open an internet browser. A customised report is available for download for each design that contains tabulated operating characteristics and informative plots, which can then be compared with other dose-escalation methods. We present a step-by-step guide on how to use this application and provide several illustrative examples of its capabilities.
CitationPLoS One, 2016, 11 (7), e0159026
Author affiliation/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Health Sciences
- VoR (Version of Record)